載入...
In Silico Discovery of Androgen Receptor Antagonists with Activity in Castration Resistant Prostate Cancer
Previously available androgen receptor (AR) antagonists (bicalutamide, flutamide, and nilutamide) have limited activity against AR in prostate cancers that relapse after castration [castration resistant prostate cancer (CRPC)]. However, recent AR competitive antagonists such as MDV3100, generated th...
Na minha lista:
| Main Authors: | , , , , , , , |
|---|---|
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Endocrine Society
2012
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3487628/ https://ncbi.nlm.nih.gov/pubmed/23023563 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/me.2012-1222 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|